Carbamazepine-Induced Toxic Effects and HLA-B1502 Screening in Taiwan - Chen, Pei; Chen, Chien-Hsiun; Chen, Ying-Ju; Chen, Yuan-Tsong; Chen, Luke; Lin, Shu-Yi; Lin, Juei-Jueng; Lin, Yu-Hsuan; Lu, Chung-Ta; Lu, Chin-Song; Lu, Cheng-Hsien; Ong, Cheung-Ter; et al. (The New England journal of medicine, 2011)
Keywords: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants - adverse effects; Anticonvulsants - therapeutic use; Anticonvulsants. Antiepileptics. Antiparkinson agents; Apoptosis; Asian Continental Ancestry Group - genetics; Biological and medical sciences; Carbamazepine - adverse effects; Carbamazepine - therapeutic use; Child; Child, Preschool; Clinical medicine; Confidence intervals; Drug-Related Side Effects and Adverse Reactions - genetics; Drug-Related Side Effects and Adverse Reactions - prevention & control; Female; General aspects; Genetic Testing; Genotype; HLA-B Antigens - genetics; HLA-B15 Antigen; Humans; Incidence; Infant; Male; Medical research; Medical sciences; Middle Aged; Neuropharmacology; Pharmacogenetics; Pharmacology. Drug treatments; Prevention and actions; Public health. Hygiene; Public health. Hygiene-occupational medicine; Stevens-Johnson Syndrome - chemically induced; Stevens-Johnson Syndrome - epidemiology; Stevens-Johnson Syndrome - genetics; Stevens-Johnson Syndrome - prevention & control; Taiwan; Young Adult; Asia; Taiwan; HLA-System; Toxicity; Major histocompatibility system; Anticonvulsant; Tricyclic compound; Medical screening; Carbamazepine; Medicine; Mood stabilizer; Carboxamide; Dibenzazepine derivatives; Class I histocompatibility antigen; HLA-B-Locus